Immature dendritic cell-derived exosomes: A promise subcellular vaccine for autoimmunity

Inflammation

Volumn 36, Issue 1, 2013, Pages 232-240

  Yin, Weifan ^a   Ouyang, Song ^b   Li, Yi ^a   Xiao, Bo ^a   Yang, Huan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Department of Neurology   (China)

Author keywords

autoimmune; dendritic cell; exosomes; therapy; vaccine

Indexed keywords

CELL PROTEIN; CYCLOPHOSPHAMIDE; EXOSOME VACCINE; LIPID; UNCLASSIFIED DRUG; VACCINE;

ADENOCARCINOMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CELL COMPOSITION; CELL MATURATION; DENDRITIC CELL; DRUG TOLERABILITY; ENTERITIS; EXOSOME; FLU LIKE SYNDROME; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE SWELLING; INTESTINE TRANSPLANTATION; LUNG NON SMALL CELL CANCER; MELANOMA; MOLECULAR GENETICS; NONHUMAN; PERIPHERAL EDEMA; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 84872909274     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9539-1     Document Type: Review

References (77)

1. Rossi, M., and J.W. Young. 2005. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. Journal of Immunology 175: 1373-1381. (Pubitemid 41023036)
2. Romani, N., B.E. Clausen, and P. Stoitzner. 2010. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunological Reviews 234: 120-141.
3. Thomson, A.W., D.A. Geller, C. Gandhi, N. Murase, A.J. Demetris, and D. Beer-Stolz. 2011. Hepatic antigen-presenting cells and regulation of liver transplant outcome. Immunologic Research 50: 2221-2227.
4. Segura, E., J. Valladeau-Guilemond, M.H. Donnadieu, X. Sastre-Garau, V. Soumelis, and S. Amigorena. 2012. Characterization of resident and migratory dendritic cells in human lymph nodes. Journal of Experimental Medicine 209: 653-660.
5. Tan, J.K., and H.C. O'Neill. 2007. Concise review: dendritic cell development in the context of the spleen microenvironment. Stem Cells 25: 2139-2145. (Pubitemid 47480471)
6. Zanoni, I., and F. Granucci. 2011. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance. Autoimmunity 4: 23-32.
7. Morva, A., S. Lemoine, A. Achour, J.O. Pers, P. Youinou, and C. Jamin. 2012. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 119: 106-114.
8. Prado, C., F. Contreras, H. González, P. Díaz, D. Elgueta, M. Barrientos, A.A. Herrada, Á. Lladser, S. Bernales, and R. Pacheco. 2012. Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. Journal of Immunology 188: 3062-3070.
9. Wang, Z., A. Sokolovska, R. Seymour, J.P. Sundberg, and H. Hogenesch. 2012. SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells. PLoS One 7: e31809.
10. Yang, H., Y. Zhang, M. Wu, J. Li, W. Zhou, G. Li, X. Li, B. Xiao, and P. Christadoss. 2010. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dendritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and Foxp3+ regulatory T cell profile. Inflammation Research 59: 197-205.
11. Wakkach, A., N. Fournier, V. Brun, J.P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
12. Zhang, X., J.R. Gordon, and J. Xiang. 2002. Advances in dendritic cell-based vaccine of cancer. Cancer Biotherapy and Radiopharmaceuticals 17: 601-619. (Pubitemid 36025942)
13. Markowicz, S., Z.I. Nowecki, P. Rutkowski, A.W. Lipkowski, M. Biernacka, A. Jakubowska-Mucka, T. Switaj, A. Misicka, H. Skurzak, H. Polowniak-Pracka, and J. Walewski. 2012. Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients. Medical Oncology. doi: 10.1007/s12032-012-0168-1.
14. Decker, W.K., and A. Safdar. 2010. Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection. Expert Review of Vaccines 9: 721-730.
15. Ren, W.N., C.K. Chang, H.H. Fan, F. Guo, Y.N. Ren, J. Yang, J. Guo, and X. Li. 2011. A combination of exosomes carrying TSA derived from HLA-A2-positive human white buffy coat and polyl: C for use as a subcellular antitumor vaccine. Journal of Immunoassay and Immunochemistry 32: 207-218.
16. Chaput, N., N.E. Schartz, F. André, J. Taïeb, S. Novault, P. Bonnaventure, N. Aubert, J. Bernard, F. Lemonnier, M. Merad, G. Adema, M. Adams, M. Ferrantini, A.F. Carpentier, B. Escudier, T. Tursz, E. Angevin, and L. Zitvogel. 2004. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. Journal of Immunology 172: 2137-2146. (Pubitemid 38182359)
17. André, F., N. Chaput, N.E. Schartz, C. Flament, N. Aubert, J. Bernard, F. Lemonnier, G. Raposo, B. Escudier, D.H. Hsu, T. Tursz, S. Amigorena, E. Angevin, and L. Zitvogel. 2004. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. Journal of Immunology 172: 2126-2136. (Pubitemid 38182358)
18. Cools, N., V.F. Van Tendeloo, E.L. Smits, M. Lenjou, G. Nijs, D.R. Van Bockstaele, Z.N. Berneman, and P. Ponsaerts. 2008. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. Journal of Cellular and Molecular Medicine 12: 690-700. (Pubitemid 351555146)
19. Oh, K., Y.S. Kim, and D.S. Lee. 2011. Maturation-resistant dendritic cells ameliorate experimental autoimmune uveoretinitis. Immune Network 11: 399-405.
20. Sun, X., Z.J. Gong, Z.W. Wang, T. Li, J.Y. Zhang, H.C. Sun, S. Liu, L. Huang, C. Huang, and Z.H. Peng. 2012. IDO-competent-DCs induced by IFN-γ attenuate acute rejection in rat liver transplantation. Journal of Clinical Immunology 32: 837-847.
21. Ezzelarab, M., and A.W. Thomson. 2011. Tolerogenic dendritic cells and their role in transplantation. Seminars in Immunology 23: 252-263.
22. Keller, S., M.P. Sanderson, A. Stoeck, and P. Altevogt. 2006. Exosomes: from biogenesis and secretion to biological function. Immunology Letters 107: 102-108. (Pubitemid 44779821)
23. Yang, C., S.H. Kim, N.R. Bianco, and P.D. Robbins. 2011. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One 6: e22517.
24. Lachenal, G., K. Pernet-Gallay, M. Chivet, F.J. Hemming, A. Belly, G. Bodon, B. Blot, G. Haase, Y. Goldberg, and R. Sadoul. 2011. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Molecular and Cellular Neuroscience 46: 409-418.
25. Mallegol, J., G. van Niel, and M. Heyman. 2005. Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Molecules and Diseases 35: 11-16. (Pubitemid 40922769)
26. Guescini, M., S. Genedani, V. Stocchi, and L.F. Agnati. 2010. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. Journal of Neural Transmission 117: 1-4.
27. Pierre, P., S.J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R.M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792. (Pubitemid 27375159)
28. Mellman, I., S.J. Turley, and R.M. Steinman. 1998. Antigen processing for amateurs and professionals. Trends in Cell Biology 8: 231-237. (Pubitemid 28243205)
29. Tamai, K., N. Tanaka, T. Nakano, E. Kakazu, Y. Kondo, J. Inoue, M. Shiina, K. Fukushima, T. Hoshino, K. Sano, Y. Ueno, T. Shimosegawa, and K. Sugamura. 2010. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochemical and Biophysical Research Communications 399: 384-390.
30. Buschow, S.I., E.N. Nolte-'t Hoen, G. van Niel, M.S. Pols, T. ten Broeke, M. Lauwen, F. Ossendorp, C.J. Melief, G. Raposo, R. Wubbolts, M.H. Wauben, and W. Stoorvogel. 2009. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10: 1528-1542.
31. Johansson, S.M., C. Admyre, A. Scheynius, and S. Gabrielsson. 2008. Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology 123: 491-499. (Pubitemid 351280963)
32. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nature Medicine 4: 594-600. (Pubitemid 28237359)
33. Aline, F., D. Bout, S. Amigorena, P. Roingeard, and I. Dimier-Poisson. 2004. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infection and Immunity 72: 4127-4137. (Pubitemid 38821928)
34. Del Cacho, E., M. Gallego, S.H. Lee, H.S. Lillehoj, J. Quilez, E.P. Lillehoj, and C. Sánchez-Acedo. 2012. Induction of protective immunity against Eimeria tenella, Eimeria maxima, and Eimeria acervulina infections using dendritic cell-derived exosomes. Infection and Immunity 80: 1909-1916.
35. Luketic, L., J. Delanghe, P.T. Sobol, P. Yang, E. Frotten, K.L. Mossman, J. Gauldie, J. Bramson, and Y. Wan. 2007. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. Journal of Immunology 179: 5024-5032.
36. Escudier, B., T. Dorval, N. Chaput, F. André, M.P. Caby, S. Novault, C. Flament, C. Leboulaire, C. Borg, S. Amigorena, C. Boccaccio, C. Bonnerot, O. Dhellin, M. Movassagh, S. Piperno, C. Robert, V. Serra, N. Valente, J.B. Le Pecq, A. Spatz, O. Lantz, T. Tursz, E. Angevin, and L. Zitvogel. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. Journal of Translational Medicine 3: 10. (Pubitemid 40617869)
37. Morse, M.A., J. Garst, T. Osada, S. Khan, A. Hobeika, T.M. Clay, N. Valente, R. Shreeniwas, M.A. Sutton, A. Delcayre, D.H. Hsu, J.B. Le Pecq, and H.K. Lyerly. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. Journal of Translational Medicine 3: 9. (Pubitemid 40617870)
38. Pêche, H., M. Heslan, C. Usal, S. Amigorena, and M.C. Cuturi. 2003. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76: 1503-1510. (Pubitemid 37467702)
39. Bianco, N.R., S.H. Kim, M.A. Ruffner, and P.D. Robbins. 2009. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis & Rheumatism 60: 380-389.
40. Kim, S.H., N.R. Bianco, W.J. Shufesky, A.E. Morelli, and P.D. Robbins. 2007. Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. Journal of Immunology 179: 2242-2249.
41. Pêche, H., K. Renaudin, G. Beriou, E. Merieau, S. Amigorena, and M.C. Cuturi. 2006. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. American Journal of Transplantation 6: 1541-1550. (Pubitemid 43945794)
42. Kim, S.H., N. Bianco, R. Menon, E.R. Lechman, W.J. Shufesky, A.E. Morelli, and P.D. Robbins. 2006. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Molecular Therapy 13: 289-300. (Pubitemid 43056894)
43. Kim, S.H., E.R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S.C. Watkins, A. Gambotto, and P.D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. Journal of Immunology 174: 6440-6448. (Pubitemid 40663838)
44. Yang, X., S. Meng, H. Jiang, C. Zhu, and W. Wu. 2011. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. Journal of Surgical Research 171: 826-832.
45. Cai, Z., W. Zhang, F. Yang, L. Yu, Z. Yu, J. Pan, L. Wang, X. Cao, and J. Wang. 2012. Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Research 22: 607-610.
46. Simpson, R.J., S.S. Jensen, and J.W. Lim. 2008. Proteomic profiling of exosomes: current perspectives. Proteomics 8: 4083-4099.
47. Simpson, R.J., J.W. Lim, R.L. Moritz, and S. Mathivanan. 2009. Exosomes: proteomic insights and diagnostic potential. Expert Review of Proteomics 6: 267-283.
48. Poliakov, A., M. Spilman, T. Dokland, C.L. Amling, and J.A. Mobley. 2009. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. The Prostate 69: 159-167.
49. Katzmann, D.J., G. Odorizzi, and S.D. Emr. 2002. Receptor downregulation and multivesicular-body sorting. Nature Reviews Molecular Cell Biology 3: 893-905. (Pubitemid 35477368)
50. Clayton, A., C.L. Harris, J. Court, M.D. Mason, and B.P. Morgan. 2003. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. European Journal of Immunology 33: 522-531. (Pubitemid 36267618)
51. Lamparski, H.G., A. Metha-Damani, J.Y. Yao, S. Patel, D.H. Hsu, C. Ruegg, and J.B. Le Pecq. 2002. Production and characterization of clinical grade exosomes derived from dendritic cells. Journal of Immunological Methods 270: 211-226.
52. Hammond, C., L.K. Denzin, M. Pan, J.M. Griffith, H.J. Geuze, and P. Cresswell. 1998. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. Journal of Immunology 161: 3282-3291.
53. Théry, C., A. Regnault, J. Garin, J. Wolfers, L. Zitvogel, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1999. Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. The Journal of Cell Biology 147: 599-610. (Pubitemid 29523465)
54. Théry, C., M. Boussac, P. Véron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosome: A secreted subcellular compartment distinct form apoptotic vesicles. Journal of Immunology 166: 7309-7318. (Pubitemid 32525606)
55. Théry, C., L. Duban, E. Segura, P. Véron, O. Lantz, and S. Amigorena. 2002. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nature Immunology 3: 1156-1162. (Pubitemid 35469700)
56. Clayton, A., J. Court, H. Navabi, M. Adams, M.D. Mason, J.A. Hobot, G.R. Newman, and B. Jasani. 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. Journal of Immunological Methods 247: 163-174. (Pubitemid 32057053)
57. Hoen, E.N., E.J. Van der Vlist, M. Aalberts, H.C. Mertens, B.J. Bosch, W. Bartelink, E. Mastrobattista, E.V. van Gaal, W. Stoorvogel, G.J. Arkesteijn, and M.H. Wauben. 2012. Quantitative and qualitative flow cytometric analysis of nano-sized cell-derived membrane vesicles. Nanomedicine: Nanotechnology, Biology and Medicine 8: 712-720.
58. Segura, E., S. Amigorena, and C. Théry. 2005. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells, Molecules and Diseases 35: 89-93. (Pubitemid 41267034)
59. Subra, C., K. Laulagnier, B. Perret, and M. Record. 2007. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89: 205-212. (Pubitemid 46161956)
60. Laulagnier, K., C. Motta, S. Hamdi, S. Roy, F. Fauvelle, J.F. Pageaux, T. Kobayashi, J.P. Salles, B. Perret, C. Bonnerot, and M. Record. 2004. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem Journal 380: 161-171. (Pubitemid 38725741)
61. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. (Pubitemid 38167318)
62. Turner, M.L., F.M. Schnorfeil, and T. Brocker. 2011. MicroRNAs regulate dendritic cell differentiation and function. Journal of Immunology 187: 3911-3917.
63. Kosaka, N., H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya. 2010. Secretory mechanisms and intercellular transfer of microRNAs in living cells. The Journal of Biology Chemistry 285: 17442-17452.
64. Vickers, K.C., and A.T. Remaley. 2012. Lipid-based carriers of microRNAs and intercellular communication. Current Opinion in Lipidology 23: 91-97.
65. Montecalvo, A., A.T. Larregina, W.J. Shufesky, D.B. Stolz, M.L. Sullivan, J.M. Karlsson, C.J. Baty, G.A. Gibson, G. Erdos, Z. Wang, J. Milosevic, O.A. Tkacheva, S.J. Divito, R. Jordan, J. Lyons-Weiler, S.C. Watkins, and A.E. Morelli. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756-766.
66. Mittelbrunn, M., C. Gutiérrez-Vázquez, C. Villarroya-Beltri, S. González, F. Sánchez-Cabo, M.Á. González, A. Bernad, and F. Sánchez-Madrid. 2011. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nature Communications 2: 282.
67. Stoorvogel, W. 2012. Functional transfer of microRNA by exosomes. Blood 119: 646-648.
68. Ramachandran, S., and V. Palanisamy. 2012. Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdisciplinary Reviews: RNA 3: 286-293.
69. Chen, X., H. Liang, J. Zhang, K. Zen, and C.Y. Zhang. 2012. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein & Cell 3: 28-37.
70. Szántó, S., T. Koreny, K. Mikecz, T.T. Glant, Z. Szekanecz, and J. Varga. 2007. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice. Arthritis Research & Therapy 9: R50. (Pubitemid 46917019)
71. Bastos-Amador, P., B. Pérez-Cabezas, N. Izquierdo-Useros, M.C. Puertas, J. Martinez-Picado, R. Pujol-Borrell, M. Naranjo-Gómez, and F.E. Borràs. 2012. Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells. Journal of Leukocyte Biology 91: 751-758.
72. Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Théry, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, E. Angevin, S. Amigorena, and L. Zitvogel. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nature Medicine 7: 297-303. (Pubitemid 32224344)
73. Fleissner, F., Y. Goerzig, A. Haverich, and T. Thum. 2012. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. American Journal of Transplantation 12: 289-297.
74. Qazi, K.R., U. Gehrmann, E. Domange Jordö, M.C. Karlsson, and S. Gabrielsson. 2009. Antigen-loaded exosomes alone induce Th1-type memory through a B cell-dependent mechanism. Blood 113: 2673-2683.
75. Delcayre, A., A. Estelles, J. Sperinde, T. Roulon, P. Paz, B. Aguilar, J. Villanueva, S. Khine, and J.B. Le Pecq. 2005. Exosome display technology: Applications to the development of new diagnostics and therapeutics. Blood Cells, Molecules, and Diseases 35: 158-168. (Pubitemid 41267044)
76. Viaud, S., M. Terme, C. Flament, J. Taieb, F. André, S. Novault, B. Escudier, C. Robert, S. Caillat-Zucman, T. Tursz, L. Zitvogel, and N. Chaput. 2009. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: A role for NKG2D ligands and IL-15Ralpha. PLoS One 4: e4942.
77. Taieb, J., N. Chaput, N. Schartz, S. Roux, S. Novault, C. Ménard, F. Ghiringhelli, M. Terme, A.F. Carpentier, G. Darrasse-Jèze, F. Lemonnier, and L. Zitvogel. 2006. Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. Journal of Immunology 176: 2722-2729.